Hello World!
Welcome to WordPress! This is your first post. Edit or delete it to
Thunder Biotech is developing MOTO-CAR™ Immunotherapy, genetically engineered macrophages, that help cancer patients’ immune cells recognize and attack solid tumors.
Thunder Biotech's purpose and passion is empowering patients to conquer cancer so they can live a joyful life, cancer free.
MOTO-CAR™ Immunotherapy: innovative macrophage technology designed to provide a more effective humane treatment for patients with solid tumors in your family and ours.
When someone develops cancer, two things have happened: mutated cells accumulate and the body’s immune system has failed to identify and eliminate them. It’s these unchecked, mutated cells that become cancer cells. Thunder Biotech is developing new therapies that help re-educate a patient’s immune system, restoring its ability to recognize and destroy cancer cells.
Traditional cancer treatments, including surgery, radiation, and chemotherapy, are invasive procedures that patients often find difficult to tolerate.
Thunder Biotech is working toward a more compassionate and effective cancer treatment. We are developing innovative MOTO-CAR™ immunotherapy treatments, which hold the promise of attacking solid tumors by activating a patient’s own immune system to eliminate cancer.
Thunder Biotech is a cancer immunotherapy company that has patented innovative treatments for cancer. This therapy genetically engineers a patient’s own immune cells (macrophages) into MOTO-CAR™s, which target specific biomarkers present on the surface of tumor cells. These MOTO-CAR™ have the ability both to identify cancer cells and to engage the patient’s immune system to attack and destroy tumor cells.
This novel technology, developed by ThunderBiotech, has tremendous potential to help patients conquer cancer. With this new approach to fighting an old disease, Thunder Biotech is emerging as a leader in CAR (Chimeric Antigen Receptor) macrophage immunotherapy cancer treatment.
We are leveraging the natural power of macrophages by engineering them to attack tumors. MOTO-CAR™s (chimeric antigen receptor macrophages) can eat away at tumors and lead to long-term, anti-tumor immunity, giving patients a promising future.
Cancer claims millions of lives each year. In the United States, approximately 600,000 people die from cancer every year, which is almost one person every minute. Worldwide, approximately 10 million people die each year from cancer — more than 19 deaths per minute.
It is very likely that you or someone you personally know and love has been diagnosed with cancer.
Cancer claims millions of lives each year. In the United States, approximately 600,000 people die from cancer every year, which is almost one person every minute. Worldwide, approximately 10 million people die each year from cancer — more than 19 deaths per minute.
It is very likely that you or someone you personally know and love has been diagnosed with cancer.
Thunder Biotech, Inc. is a private biotechnology company offering investors the opportunity to help conquer cancer.
Copyright © 2022 Thunder Biotech. All rights reserved.